High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

Leukemia. 2021 Aug;35(8):2412-2415. doi: 10.1038/s41375-021-01124-5. Epub 2021 Jan 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • China / epidemiology
  • DNA-Binding Proteins / genetics*
  • Female
  • Humans
  • Incidence
  • Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Male
  • Mutation*
  • Myeloid Differentiation Factor 88 / genetics*
  • Neoplasm Proteins / genetics*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • KMT2D protein, human
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • Neoplasm Proteins